Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > ATS Volume 2 million
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(169)
•••
Comment by DigitalSpurson Apr 09, 2020 1:48pm
115 Views
Post# 30894999

RE:RE:RE:RE:RE:RE:ATS Volume 2 million

RE:RE:RE:RE:RE:RE:ATS Volume 2 millionI'm very confident in this! As i discussed yesterday (look at my history), the low volume on this is a technical indicator, especially considering some people are dying to in around 10c, but very few are selling. Look at the price history for the stock and you tell me that with the technical indicators, the news release, the funding/backers and the need for treatment of Covid19 that this is going to fall and go back to 2c a share? There is no way!! Check out the price history and you will see support is strong in this handle part of the cup and handle pattern and that a HUGE breakout is imminent! No one invests, especially up to $6 million, on a hunch or a maybe. Guy has been in regular contact with me anytime I ask for an update, not including anything that would be considering fishing, but he and their team have been MIA this whole week. Let their actions do the talking for us. Feels to me they are hitting the ground hard and are working hard on getting things sorted. His success is our success. He has nothing to gain from this deal and the investors have a lot to lose.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities